Sign Distribution Agreement - Emcure Pharmaceuticals Ltd

Code BSE: 544210 NSE:

Emcure Pharmaceuticals and Roche Sign Distribution Agreement to Strengthen Nephrology and Transplant Care in India Emcure Pharmaceuticals Ltd today announced the signing of a distribu,on agreement with Roche for select products in the nephrology and transplant medicine porJolio. The agreement marks a significant step toward expanding pa,ent access to crical therapies in chronic kidney disease (CKD), anemia management, and transplant care across India. Under the agreement, which will be effec,ve April 1, 2026, Emcure will distribute Roche’s established and globally recognised brands in the nephrology and transplant segment in India.